-

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Phreesia, Inc. (PHR)

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). The investigation concerns whether Phreesia and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

[Click here to learn more about the investigation]

On May 30, 2024, Phreesia issued a press release announcing financial results for the first quarter of the fiscal year 2025. Among other items, Phreesia update its “revenue outlook for fiscal year 2025 to a range of $416 million to $426 million from a previous range of $424 million to $434 million.” Phreesia advised that “[t]he updated revenue range incorporates the accelerated winddown of a clearinghouse client relationship” and that “[t]he revenue range provided for fiscal 2025 assumes no additional revenue from potential future acquisitions completed between now and January 31, 2025.” On this news, the price of Phreesia shares declined by $2.39 per share, or approximately 11.22%, from $21.31 on May 30, 2024, to close at $18.92 per share on May 31, 2024.

If you purchased or otherwise acquired Phreesia securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this CONTACT FORM, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NYSEAM:PHR

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

TTGT Investigation: Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of TechTarget, Inc. (“TechTarget” or the “Company”) (NASDAQ:TTGT) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On December 6, 2024, TechTarget disclosed that its previous financial statements “should no longer be relie...

OWL ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Blue Owl Capital Inc. Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Blue Owl Capital (“Blue Owl” or the “Company”) (NYSE:OWL) securities during the period of February 6, 2025 through November 16, 2025, inclusive (“the Class Period”). If you suffered a loss on your Blue Owl investments, you have until February 2, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERED A...

JYD ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Jayud Global Logistics Limited Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Jayud Global Logistics Limited (“Jayud” or the “Company”) (NASDAQ:JYD) securities during the period of April 21, 2023 through April 30, 2025, inclusive (“the Class Period”). If you suffered a loss on your Jayud investments, you have until January 20, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFE...
Back to Newsroom